Medical Services

Acute Lymphoblastic Leukemia (ALL) is a fast-growing cancer of the blood and bone marrow that primarily affects white blood cells (lymphocytes). It occurs when immature lymphoblasts multiply uncontrollably, crowding out healthy cells, and impairing the body’s ability to fight infections. ALL is most common in children but can also affect adults, often with more aggressive progression.

Symptoms of ALL may include persistent fever, fatigue, frequent infections, easy bruising, bone pain, and swollen lymph nodes. Early detection is crucial as the disease can progress rapidly. Diagnosis typically involves blood tests, bone marrow biopsy, and specific genetic studies to identify chromosomal abnormalities that guide treatment planning.

Treatment options for ALL are intensive and multi-phased, generally starting with chemotherapy to induce remission. This may be followed by targeted therapy, immunotherapy, radiation, or stem cell transplantation depending on the subtype and patient’s age. Advances in personalized medicine have significantly improved survival rates, especially in children.

With timely treatment, many patients achieve remission and long-term survival. Supportive care, including infection prevention, nutritional management, and psychological support, also plays an essential role in improving quality of life during and after treatment.